Left ventricular ejection fraction: clinical, pathophysiological, and technical limitations
Frontiers in Cardiovascular Medicine · 07.02.2024 · 11
DOI: 10.3389/fcvm.2024.1340708 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 07.02.2024. Verfasst von Federico Vancheri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, S.Elia Hospital, Caltanissetta, Italy. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Risk stratification of cardiovascular death and treatment strategies in patients with heart failure (HF), the optimal timing for valve replacement, and the selection of patients for implantable cardioverter defibrillators are based on an echocardiographic calculation of left ventricular ejection fraction (LVEF) in most guidelines. As a marker of systolic function, LVEF has important limitations being affected by loading conditions and cavity geometry, as well as image quality, thus impacting inter- and intra-observer measurement variability. LVEF is a product of shortening of the three components of myocardial fibres: longitudinal, circumferential, and oblique. It is therefore a marker of global ejection performance based on cavity volume changes, rather than directly reflecting myocardial contractile function, hence may be normal even when myofibril's systolic function is impaired. Sub-endocardial longitudinal fibers are the most sensitive layers to ischemia, so when dysfunctional, the circumferential fibers may compensate for it and maintain the overall LVEF. Likewise, in patients with HF, LVEF is used to stratify subgroups, an approach that has prognostic implications but without a direct relationship. HF is a dynamic disease that may worsen or improve over time according to the underlying pathology. Such dynamicity impacts LVEF and its use to guide treatment. The same applies to changes in LVEF following interventional procedures. In this review, we analyze the clinical, pathophysiological, and technical limitations of LVEF across a wide range of cardiovascular pathologies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, S.Elia Hospital, Caltanissetta, Italy.
- Cardiovascular and Interventional Department, S.Elia Hospital, Caltanissetta, Italy.
- Institute of Public Health and Clinical Medicine, Umea University, Umea, Sweden.
Zitieren
APA
Vancheri, F., Longo, G., & Henein, M. Y. (2024). Left ventricular ejection fraction: clinical, pathophysiological, and technical limitations. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1340708
Vancouver
Vancheri F, Longo G, Henein MY. Left ventricular ejection fraction: clinical, pathophysiological, and technical limitations. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1340708
BibTeX
@article{Vancheri2024,
author = {Vancheri, Federico and Longo, Giovanni and Henein, Michael Y},
title = {Left ventricular ejection fraction: clinical, pathophysiological, and technical limitations},
journal = {Frontiers in Cardiovascular Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fcvm.2024.1340708}
}
EUVIMED